Shu-Chi Wang
Papers
2
Total Citations
11
H-Index
2
About
Dr. Shu-Chi Wang is a urological surgeon and researcher whose work focuses on optimizing treatment strategies for prostate cancer and benign prostatic hyperplasia (BPH). His key research areas include active surveillance protocols for low-risk prostate cancer and the advancement of minimally invasive surgical techniques. In his highly cited 2017 study, Dr. Wang critically evaluated pathological outcomes in men eligible for active surveillance, revealing that a significant subset harbored adverse pathology—a finding that has informed risk stratification and patient counseling, with 6 citations underscoring its clinical relevance. He also pioneered the adoption of robotic simple prostatectomy in Taiwan, as detailed in his 2016 paper (5 citations), demonstrating the safety and efficacy of this approach for large-volume BPH. By comparing outcomes to traditional open and laparoscopic methods, Dr. Wang has helped establish robotic surgery as a viable, less invasive option, improving recovery for patients. His work bridges the gap between conservative management and surgical innovation, directly impacting urological practice in Asia. Dr. Wang’s contributions continue to shape evidence-based decision-making for prostate conditions.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robotic simple prostatectomy: Initial single-center experience in Taiwan5 citations · 2016